| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |